Calliditas Therapeutics Ab Price to Earnings Ratio (PE) Ratios, (CALT) Valuation Ranking and Trends, Fundamental Ratios - CSIMarket
CSIMarket
 




Calliditas Therapeutics Ab  (NASDAQ: CALT)
 





CALT Price to Earnings Ratio Current 0 0 0 (Dec 31 2022)
Diluted EPS 12 Trailing Months III. Quarter II. Quarter I. Quarter IV. Quarter
PE (TTM) Ratio current            -            -            -            -            -
Diluted EPS TTM Y / Y Change 11.69 % - % - % - % - %
Diluted EPS Y / Y Change 11.69 % - % -52.76 % - % - %
Stock performance to date 150 % -14.75 % -18.51 % 17.29 % 33.33 %

Price to earnings ratio Comment
Calliditas Therapeutics Ab's recorded net loss in trailing twelve months.

Within Healthcare sector 14 other companies have lower Price to earnings ratio.

What is Price to Earnings Ratio?
What is Calliditas Therapeutics Ab Market Share?

Price to earnings ratio Company Ranking
Within: No.
Industry #11
Sector #15
S&P 500 #47





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.